Forecast: Import of Pharmaceutical Products to Angola

The import of pharmaceutical products to Angola saw significant fluctuations over the past decade. From 2013 to 2014, there was a notable increase of 28.03%, but this was followed by a sharp decline of 24.86% in 2015. The trend continued with a decrease in subsequent years until 2017, when imports picked up again with a 21.73% rise. The years 2018 to 2020 were marked by increases, notably 22.77% in 2018. However, 2021 and 2022 saw minor fluctuations with a small decline of 1.6% in 2022. The latest actual value in 2023 reported a moderate increase of 3.15%, bringing the overall import value to 388.01 million USD.

Looking ahead, forecasted data from 2024 onwards show a consistent but gradual increase in imports, with the compound annual growth rate (CAGR) for the next five years projected at 2.07%. By 2028, imports are expected to reach 444.51 million USD, reflecting a forecasted five-year growth rate of 10.81%.

Future trends to watch for include:

• The impact of Angola's economic stability and healthcare policies on pharmaceutical imports.
• Potential shifts in global pharmaceutical supply chains and their effects on Angolan imports.
• The evolution of healthcare needs and disease patterns in Angola, which could influence the demand for various pharmaceutical products.